ADAPTIVE BIOTECHNOLOGIES (ADPT) Forecast, Price Target & Analyst Ratings

NASDAQ:ADPT • US00650F1093

Current stock price

13.58 USD
+0.08 (+0.59%)
At close:
14.25 USD
+0.67 (+4.93%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADAPTIVE BIOTECHNOLOGIES (ADPT).

Forecast Snapshot

Consensus Price Target

Price Target
$21.27
+ 56.66% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.16
Revenue Estimate
61.921M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.29%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$21.27
Upside
+ 56.66%
From current price of $13.58 to mean target of $21.27, Based on 14 analyst forecasts
Low
$20.20
Median
$21.42
High
$23.10

Price Target Revisions

1 Month
4.29%
3 Months
2.82%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for ADPT. The average price target is 21.27 USD. This implies a price increase of 56.66% is expected in the next year compared to the current price of 13.58.
The average price target has been revised upward by 2.82% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ADPT Current Analyst RatingADPT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ADPT Historical Analyst RatingsADPT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.29%
ADPT was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ADPT.
In the previous month the buy percentage consensus was at a similar level.
ADPT was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-06BTIGMaintains Buy -> Buy
2026-02-06JP MorganMaintains Overweight -> Overweight
2026-01-26GuggenheimMaintains Buy -> Buy
2025-11-11Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-11-06BTIGMaintains Buy -> Buy
2025-11-06JP MorganMaintains Overweight -> Overweight
2025-10-22BTIGMaintains Buy -> Buy
2025-10-15Piper SandlerMaintains Overweight -> Overweight
2025-10-13JP MorganMaintains Overweight -> Overweight
2025-09-30GuggenheimInitiate Buy
2025-08-06TD CowenMaintains Buy -> Buy
2025-08-06JP MorganMaintains Overweight -> Overweight
2025-08-06Piper SandlerMaintains Overweight -> Overweight
2025-06-18Craig-HallumInitiate Buy
2025-05-06Piper SandlerMaintains Overweight -> Overweight
2025-05-05Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-05-02Goldman SachsMaintains Buy -> Buy
2025-03-21Goldman SachsUpgrade Neutral -> Buy
2025-02-20Piper SandlerReiterate Overweight -> Overweight
2025-02-13ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-01-28Goldman SachsMaintains Neutral -> Neutral
2024-12-18BTIGMaintains Buy -> Buy
2024-11-11Piper SandlerMaintains Overweight -> Overweight
2024-10-02BTIGMaintains Buy -> Buy
2024-08-02JP MorganMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.16
Revenue Estimate
61.921M
Revenue Q2Q
18.07%
EPS Q2Q
19.04%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
0.77%
Revenue (3 Months)
2.78%
EPS (1 Month)
1.55%
EPS (3 Months)
5.93%

Next Earnings Summary

ADPT is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is -0.16 USD and the consensus revenue estimate is 61.92M USD.
The next earnings revenue estimate has been revised upward by 2.78% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ADPT revenue by date.ADPT revenue by date.
170.276M
-8.11%		178.957M
5.10%		276.976M
54.77%		288M
3.98%		353.44M
22.72%		423.54M
19.83%		515.2M
21.64%		654.33M
27.01%
EBITDA
YoY % growth
ADPT ebitda by date.ADPT ebitda by date.
-179.375M
-0.94%		-136.088M
24.13%		-39.29M
71.13%		-14.198M
63.86%		27.834M
296.04%		39.737M
42.76%		86.904M
118.70%		71.4M
-17.84%
EBIT
YoY % growth
ADPT ebit by date.ADPT ebit by date.
-201.606M
-1.51%		-155.344M
22.95%		-57.123M
63.23%		-72.833M
-27.50%		-37.697M
48.24%		-5.187M
86.24%		15.504M
398.90%
-100.00%
Operating Margin
ADPT operating margin by date.ADPT operating margin by date.
-118.40%-86.81%-20.62%-25.29%-10.67%-1.22%3.01%N/A
EPS
YoY % growth
ADPT eps by date.ADPT eps by date.
-1.38
2.13%		-1.09
21.01%		-0.40
63.30%		-0.49
-23.67%		-0.27
45.36%		-0.06
79.25%		0.09
254.55%		-0.01
-111.76%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth		-0.16
19.04%		-0.14
20.50%		-0.15
-342.25%		-0.13
-43.08%		-0.13
21.26%		-0.07
50.94%		-0.10
33.33%		-0.07
48.51%		-0.05
60.00%		0.01
115.38%		-0.08
15.79%
Revenue
Q2Q % growth		61.921M
18.07%		67.454M
14.56%		70.264M
-25.23%		74.239M
3.57%		71.043M
14.73%		84.915M
25.89%		85.272M
21.36%		90.066M
21.32%		92.004M
29.50%		104.04M
22.52%		99.654M
16.87%
EBITDA
Q2Q % growth		-6.683M
73.13%		-2.655M
83.20%		3.998M
-83.29%		2.137M
-57.77%		-2.04M
69.47%		10.261M
486.54%		14.015M
250.55%		19.237M
800.19%		N/AN/AN/A
EBIT
Q2Q % growth		-25.013M
15.51%		-20.388M
18.56%		-22.097M
-314.74%		-20.066M
-57.10%		-20.212M
19.20%		-10.053M
50.69%		-14.578M
34.03%		-9.98M
50.27%		N/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ADPT Yearly Revenue VS EstimatesADPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
ADPT Yearly EPS VS EstimatesADPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.98%
EPS Next 5 Year
14.58%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
16.20%
Revenue Next 5 Year
19.37%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
36.37%
EBIT Next 5 Year
24.27%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ADAPTIVE BIOTECHNOLOGIES / ADPT Forecast FAQ

What do analysts expect the price target to be for ADAPTIVE BIOTECHNOLOGIES (ADPT)?

14 analysts have analysed ADPT and the average price target is 21.27 USD. This implies a price increase of 56.66% is expected in the next year compared to the current price of 13.58.

What is the next earnings date for ADPT stock?

ADAPTIVE BIOTECHNOLOGIES (ADPT) will report earnings on 2026-04-29, after the market close.

Can you provide the consensus estimates for ADAPTIVE BIOTECHNOLOGIES next earnings?

The consensus EPS estimate for the next earnings of ADAPTIVE BIOTECHNOLOGIES (ADPT) is -0.16 USD and the consensus revenue estimate is 61.92M USD.

Can you provide the consensus rating for ADAPTIVE BIOTECHNOLOGIES stock?

The consensus rating for ADAPTIVE BIOTECHNOLOGIES (ADPT) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.